Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of the Safety and Effectiveness of Benralizumab to Treat Patients With Severe Uncontrolled Asthma.

ClinicalTrials.gov ID: NCT03170271

Public ClinicalTrials.gov record NCT03170271. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 12:46 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-blind, Parallel Group, Placebo Controlled, Phase 3b Study to Evaluate the Safety and Efficacy of Benralizumab 30 mg sc in Patients With Severe Asthma Uncontrolled on Standard of Care Treatment

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to investigate the effect of benralizumab on the rate of asthma exacerbations, patient reported quality of life and lung function during the 24-week treatment in patients with uncontrolled, severe asthma with an eosinophilic phenotype. A subset of patients will be assessed for their ongoing chronic rhinosinusitis with nasal polyps. The study design has been updated to include a 56-week open label ANDHI in Practice (ANDHI IP) sub study upon the completion of the 24-week double-blind period of the ANDHI study.

Study identification

NCT ID
NCT03170271
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
660 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 7, 2017 (Actual)
Primary completion
Sep 25, 2019 (Actual)
Completion
Oct 21, 2020 (Actual)
Last update posted
Nov 1, 2021

2017 – 2020

United States locations

U.S. sites
100
U.S. states
37
U.S. cities
90
Facility City State ZIP Site status
Research Site Birmingham Alabama 35209 —
Research Site Tucson Arizona 85724 —
Research Site Little Rock Arkansas 72209 —
Research Site Bakersfield California 93301 —
Research Site Encinitas California 92024 —
Research Site Long Beach California 90806 —
Research Site Los Angeles California 90025 —
Research Site Mission Viejo California 92691 —
Research Site Newport Beach California 92663 —
Research Site Riverside California 92506 —
Research Site San Diego California 92108 —
Research Site Stockton California 95207 —
Research Site Walnut Creek California 94598 —
Research Site Aurora Colorado 80045 —
Research Site New Haven Connecticut 06519 —
Research Site Waterbury Connecticut 06708 —
Research Site Clearwater Florida 33765 —
Research Site Jacksonville Florida 32099 —
Research Site Kissimmee Florida 34741 —
Research Site Miami Florida 33126 —
Research Site Miami Florida 33173 —
Research Site Winter Park Florida 32789 —
Research Site Albany Georgia 31707 —
Research Site Savannah Georgia 31406 —
Research Site Peoria Illinois 61602 —
Research Site South Bend Indiana 46617 —
Research Site Iowa City Iowa 52242 —
Research Site West Des Moines Iowa 50266 —
Research Site Lakeside Park Kentucky 41017 —
Research Site Owensboro Kentucky 42301 —
Research Site Shreveport Louisiana 71106 —
Research Site Chevy Chase Maryland 20815 —
Research Site White Marsh Maryland 21162 —
Research Site North Dartmouth Massachusetts 02747 —
Research Site Ann Arbor Michigan 48109 —
Research Site Ypsilanti Michigan 48197 —
Research Site Minneapolis Minnesota 55402 —
Research Site St Louis Missouri 63156 —
Research Site Missoula Montana 59808 —
Research Site Lincoln Nebraska 68510 —
Research Site Highland Park New Jersey 08904 —
Research Site Marlton New Jersey 08053 —
Research Site Northfield New Jersey 08225 —
Research Site Piscataway New Jersey 08854 —
Research Site Toms River New Jersey 08755 —
Research Site Verona New Jersey 07044 —
Research Site Albuquerque New Mexico 87106 —
Research Site New Hyde Park New York 11042 —
Research Site New York New York 10016 —
Research Site Rochester New York 14618 —
Research Site Staten Island New York 10305 —
Research Site Staten Island New York 10310 —
Research Site The Bronx New York 10459 —
Research Site Charlotte North Carolina 28277 —
Research Site Elizabeth City North Carolina 27909 —
Research Site Gastonia North Carolina 28054 —
Research Site Greenville North Carolina 27834 —
Research Site High Point North Carolina 27262 —
Research Site Winston-Salem North Carolina 27103 —
Research Site Winston-Salem North Carolina 27157 —
Research Site Cincinnati Ohio 45231 —
Research Site Cincinnati Ohio 45242 —
Research Site Grove City Ohio 43123 —
Research Site Edmond Oklahoma 73034 —
Research Site Tulsa Oklahoma 74136 —
Research Site Clackamas Oregon 97015-5737 —
Research Site Philadelphia Pennsylvania 19107 —
Research Site Pittsburgh Pennsylvania 15213 —
Research Site Pittsburgh Pennsylvania 15241 —
Research Site Reading Pennsylvania 19610 —
Research Site Anderson South Carolina 29621 —
Research Site Gaffney South Carolina 29340 —
Research Site Greenville South Carolina 29607 —
Research Site Greenville South Carolina 29615 —
Research Site North Charleston South Carolina 29420-4211 —
Research Site Rock Hill South Carolina 29732 —
Research Site Sioux Falls South Dakota 57108 —
Research Site Franklin Tennessee 37067 —
Research Site Cypress Texas 77429 —
Research Site Dallas Texas 75225 —
Research Site Dallas Texas 75246 —
Research Site Fort Worth Texas 76109 —
Research Site Galveston Texas 77555 —
Research Site McKinney Texas 75069 —
Research Site San Antonio Texas 78229 —
Research Site San Antonio Texas 78249 —
Research Site San Antonio Texas 78251 —
Research Site Provo Utah 84604 —
Research Site South Burlington Vermont 05403 —
Research Site Abingdon Virginia 24210 —
Research Site Fairfax Virginia 22030 —
Research Site North Chesterfield Virginia 23225 —
Research Site Williamsburg Virginia 23188 —
Research Site Everett Washington 98208 —
Research Site Spokane Washington 99204 —
Research Site Tacoma Washington 98405 —
Research Site Madison Wisconsin 53792 —
Research Site Milwaukee Wisconsin 53226 —
Research Site Milwaukee Wisconsin 53228 —
Research Site West Allis Wisconsin 53227 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 113 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03170271, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 1, 2021 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03170271 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →